Company Data
GRI Bio Inc.
Ticker
GRI
Current Price
$1.26 -0.79%
Market Cap
$640.2K
Price Target
Refer to Report
Volume
498.9K
52wk Range
$1.15 - $349.895
Overview
Vallon Pharmaceuticals Inc is a biopharmaceutical company, which focuses on the development and commercialization of proprietary biopharmaceutical products. The company develops prescription drugs for central nervous system disorders. Its product ADAIR, a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder, and narcolepsy.